Aktie A2H8RX BIO-GENE TECHNOLOGY LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Bio-Gene Technology Limited

Aktien

A2H8RX

AU000000BGT8

BGT

Markt geschlossen - Australian S.E.
Andere Börsenplätze
 07:14:36 07.05.2024 		% 5 Tage % 1. Jan.
0,06 AUD -13,04 % Intraday Chart für Bio-Gene Technology Limited -13,04 % 0,00 %
25.02. Bio-Gene Technology Limited berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Halbjahr CI
2023 Bio-Gene Technology Limited stimmt der Wahl von Alex Ding zum Direktor zu CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Bio-Gene Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2023
Bio-gene Technology Secures R&D Tax Rebate for Fiscal Year 2023
Bio-Gene Technology Limited Approves the Election of Alex Ding as Director
Bio-Gene Technology Limited Announces Resignation of Rodrigo Valencia as Joint CFO
Bio-Gene Technology Limited Announces the Resignation of Rodrigo Valencia as Company Secretary
Bio-Gene Technology Limited Announces the Appointment of Roger Mcpherson as Joint Company Secretary
Bio-Gene Technology Raises Further Funds Under Placement, SPP; Shares Slip 3%
Bio-Gene Technology to Raise AUD 2.5 Million
Bio-Gene Technology Limited Appoints Owen Timothy Grogan as Director
Bio-gene Technology Secures US Patent for Insecticide Product
Bio-Gene Technology Limited Reports Earnings Results for the Full Year Ended June 30, 2023
Bio-Gene Technology Limited Announces Managing Director Changes
Bio-Gene Technology Limited Announces Chief Executive Officer Changes
Bio-Gene Technology Limited Appoints Alex Huong Soo Ding as Director
Bio-Gene Technology Limited Appoints Christopher Mark Ramsey as Director
Bio-Gene Technology Limited Announces Changes to the Board
Altor Capital Management Pty Ltd Withdraws its Notices
Government Research Entity Supports Commercialization of Bio-Gene Technology's Insecticide; Shares Soar 21%
Bio-Gene Technology Limited Announces Extension of the Licence and Development Agreement with Clarke for the United States and Cayman Islands
Bio-Gene Technology Limited Appoints Rod Valencia as CFO and Company Secretary
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2H8RX Aktie
  4. Nachrichten Bio-Gene Technology Limited
  5. Andere Sprachen